Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LMDX

LumiraDx (LMDX) Stock Price, News & Analysis

LumiraDx logo

About LumiraDx Stock (NASDAQ:LMDX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.0076
$0.0160
52-Week Range
N/A
Volume
132.24 million shs
Average Volume
56.75 million shs
Market Capitalization
$5.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LMDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LumiraDx and its competitors with MarketBeat's FREE daily newsletter.

LMDX Stock News Headlines

LumiraDx Ltd LMDXF
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
LMDX.O
Why Is LumiraDx (LMDX) Stock Down 13% Today?
See More Headlines

LMDX Stock Analysis - Frequently Asked Questions

LumiraDx Limited (NASDAQ:LMDX) announced its quarterly earnings data on Thursday, August, 24th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.15) by $0.01. The business earned $21 million during the quarter, compared to analysts' expectations of $21.07 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that LumiraDx investors own include Predictive Oncology (POAI), Ford Motor (F), Bank of America (BAC), Abbott Laboratories (ABT), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM) and Wayfair (W).

Company Calendar

Last Earnings
8/24/2023
Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LMDX
Fax
N/A
Employees
1,210
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$447.79 million
Net Margins
-268.45%
Pretax Margin
-264.58%

Debt

Sales & Book Value

Annual Sales
$126.52 million
Price / Cash Flow
N/A
Book Value
($0.33) per share
Price / Book
N/A

Miscellaneous

Free Float
205,749,000
Market Cap
$5.10 million
Optionable
Not Optionable
Beta
1.73
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:LMDX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners